Navigation Links
Gene Therapy May Treat Erectile Dysfunction
Date:5/20/2008

Studies in both men and monkeys show effectiveness of treatment

TUESDAY, May 20 (HealthDay News) -- Gene therapy may be a way to treat erectile dysfunction in men who do not respond to pills such as Viagra, researchers report.

Maxi-K gene therapy is a gene transfer that improves erectile dysfunction. Two studies using the gene were presented Tuesday at the American Urological Association's annual meeting, in Orlando, Fla.

"Gene transfer technology has the potential for long-term improvement for erectile function," lead researcher Dr. Arnold Melman, a professor of medicine at Albert Einstein College of Medicine in New York City, said during a morning teleconference Tuesday.

"The market for erectile dysfunction is quite large," Melman said. "And medications such as Viagra don't work very well in 40 percent of men."

Melman noted that a recent survey showed that 50 percent of urologists would consider switching their patients from their current medications to gene transfer treatment. "So, we think this will be well-accepted by physicians and patients," he said.

Results of a phase I trial testing gene transfer in 11 men with erectile dysfunction who had failed other therapy showed that gene transfer was safe and also had restorative effects. Four different doses were tried during the trial. Men receiving the highest dose showed improvement for up to six months, Melman said.

"These men had normal sexual function for six months and then went back to the way they were," Melman said. He added that two doses a year would be enough for most men to maintain their normal sexual function.

During two years of follow-up, none of the men reported any abnormalities after the gene transfer. The procedure was safe, and no adverse effects were seen, Melman said.

Based on these findings, Melman's group is moving on to new trials and hopes to have a product on the market within two years.

In another trial, four monkeys were fed a high-fat diet, which reduced their sex drive. After the monkeys received a Maxi-K gene transfer, they became friskier.

In addition, the number of partial and full erections increased about fivefold, the researchers found. Also, the frequency of ejaculations increased among the monkeys that received the gene transfer. Moreover, the gene transfer affected how the monkeys behaved with female monkeys.

"The most fascinating thing is there was the increased socialization," lead researcher George J. Christ, a professor of urology and head of the Program in Cell Tissue and Organ Physiology at the Wake Forest Institute for Regenerative Medicine, said during Tuesday's teleconference. "After receiving a gene transfer and regaining sexual function, they felt better about themselves."

More information

For more on erectile dysfunction, visit the National Institute of Diabetes and Digestive and Kidney Diseases.



SOURCES: May 20, 2008, teleconference with Arnold Melman, M.D., professor, medicine, Albert Einstein College of Medicine, New York City; George J. Christ, Ph.D., professor, urology, and head, Program in Cell, Tissue and Organ Physiology, Wake Forest Institute for Regenerative Medicine, Winston-Salem, N.C., May 20, 2008, presentations, American Urological Association annual meeting, Orlando, Fla.


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Invasive methods unnecessary for prostate cancer radiation therapy treatment planning
2. A potential route for human tumor gene therapy
3. New patient satisfaction study with budesonide/formoterol combination therapy
4. Hormone Therapy Safe, Effective for Women Entering Menopause
5. Self Help Therapy for Veterans with Traumatic Brain Injury (TBI)
6. Personalized therapy for asthma and COPD could soon be here
7. Not All Colon Cancer Patients Need Chemotherapy: Study
8. New Therapy Kills Human Leukemia Cells in Mice
9. Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy
10. Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
11. Adding epratuzumab to standard therapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene Therapy May Treat Erectile Dysfunction
(Date:12/5/2016)... ... December 05, 2016 , ... ... the 21st Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and ... Talamo said, “We are honored to have Amy E. Herman present at this ...
(Date:12/5/2016)... ... December 05, 2016 , ... Dr. Barry M. Weintraub, one of New ... recently participated in the 36th Annual Cutting Edge Aesthetic Symposium at the Waldorf Astoria ... getting that perfect, yet natural-looking, nose. Dr. Weintraub, who is world-renowned for his expertise ...
(Date:12/5/2016)... MALVERN, PA (PRWEB) , ... ... ... Management ("CSM"), a Great Point Partners ("GPP") portfolio company, today announced it ... Clinical Supplies ("TCS"). TCS was previously a subsidiary of Chiltern International ...
(Date:12/5/2016)... ... ... Shah MD, MBA has joined the Retina Group of New York (RGONY) specializing ... M. Maisel, MD and has been providing tertiary medical and surgical retinal care on Long ... expectations amongst her peers. Growing up in a family of doctors, Dr. Shah emulated ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... the 2016 Anti-Aging & Beauty Awards at The Aesthetic & Anti-aging Medicine ... Medicine European Congress (AMEC) brings together the industry’s leading scientific experts, speakers, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... PUNE, India , December 5, 2016 ... Market by Product Type and by Application - Global Opportunity Analysis and Industry ... in 2015, and is expected to reach $5,255 million by 2022, growing at ... market in 2015 with more than four-fifths share. ... ...
(Date:12/5/2016)... Dec. 5, 2016  Wellbridge Health and Gateway Health proudly ... solutions to Medicare and Medicaid plan members with specific high ... the unique needs of this group of consumers, Wellbridge combines ... philosophies to provide insight into members, daily behaviors and lifestyle. ... , , ...
(Date:12/5/2016)... For the third consecutive year, Astellas has ... Rights Campaign Foundation,s (HRC) annual Corporate Equality ... tool used to rate companies on policies and practices ... For the last 15 years, HRC has ... equality efforts, culture and business practices. The survey rates ...
Breaking Medicine Technology: